| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |